Hims & Hers Health Inc [NYSE: HIMS] price surged by 1.48 percent to reach at $0.26.
The one-year HIMS stock forecast points to a potential upside of 15.65. The average equity rating for HIMS stock is currently 2.08, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Hims & Hers Health Inc [HIMS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIMS shares is $21.15 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIMS stock is a recommendation set at 2.08. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Hims & Hers Health Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 22, 2024. While these analysts kept the previous recommendation, Jefferies dropped their target price from $17 to $15. The new note on the price target was released on April 16, 2024, representing the official price target for Hims & Hers Health Inc stock. Previously, the target price had yet another raise to $20, while Canaccord Genuity analysts kept a Buy rating on HIMS stock.
The Average True Range (ATR) for Hims & Hers Health Inc is set at 1.74, with the Price to Sales ratio for HIMS stock in the period of the last 12 months amounting to 3.99. The Price to Book ratio for the last quarter was 11.10, with the Price to Cash per share for the same quarter was set at 0.95. Price to Free Cash Flow for HIMS in the course of the last twelve months was 73.83 with Quick ratio for the last quarter at 2.48.
HIMS Stock Performance Analysis:
Hims & Hers Health Inc [HIMS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -17.83. With this latest performance, HIMS shares dropped by -14.15% in over the last four-week period, additionally plugging by 101.13% over the last 6 months – not to mention a rise of 117.56% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HIMS stock in for the last two-week period is set at 37.45, with the RSI for the last a single of trading hit 31.25, and the three-weeks RSI is set at 41.89 for Hims & Hers Health Inc [HIMS]. The present Moving Average for the last 50 days of trading for this stock 21.14, while it was recorded at 19.27 for the last single week of trading, and 13.25 for the last 200 days.
Insight into Hims & Hers Health Inc Fundamentals:
Hims & Hers Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.48 and a Current Ratio set at 2.80.
Hims & Hers Health Inc [HIMS] Institutonal Ownership Details
The top three institutional holders of HIMS stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in HIMS stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in HIMS stock with ownership which is approximately 5.1238%.
